Management of Intestinal Obstruction in the Terminal Patient and Management of Ascites

Gynecologic Cancer: Controversies in Management

Volumn , Issue , 2004, Pages 727-741

  Chu, Christina S ^a   Rubin, Stephen C ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84902220811     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-443-07142-3.50058-0     Document Type: Chapter

References (156)

1. SC Rubin, WJ Hoskins, I Benjamin and JL Lewis (1989) Palliative surgery for intestinal obstruction in advanced ovarian cancer. Gynecol Oncol 34 16-19.
2. MS Piver, JJ Barlow, SB Lele and A Frank (1982) Survival after ovarian cancer induced intestinal obstruction. Gynecol Oncol 13 44-49.
3. L McGowan (1978) Gynecologic Oncology New York: Appleton-Century-Crofts 298-299.
4. PJ DiSaia, CP Morrow and DE Townsend (1975) Synopsis of Gynecologic Oncology New York: Wiley 161.
5. C Ripamonti, F DeConno, V Ventafridda, et al. (1993) Management of bowel obstruction in advanced and terminal cancer patients. Ann Oncol 4 15-21.
6. PM Dvoretsky, KA Richards, A Angel, et al. (1988) Survival time, causes of death, and tumor-treatment-related morbidity in 100 women with ovarian cancer. Hum Pathol 19 1273-1279.
7. PM Dvoretsky, KA Richards, C Angel, et al. (1988) Distribution of disease at autopsy in 100 women with ovarian cancer. Hum Pathol 19 57-63.
8. PG Rose, S Piver, Y Tsukada and T Lau (1978) Metastatic patterns in histologic variants of ovarian cancer-an autopsy study. Cancer 64 1508-1513.
9. GJ Beattie, R Leonard and JF Smyth (1989) Bowel obstruction in ovarian carcinoma: A retrospective study and review of the literature. Palliat Med 3 275-280.
10. AMM Paganelli, V Leone, V Malagutti, et al. (1990) Intestinal surgery in patients with ovarian carcinoma. Eur J Gynecol Oncol 11 157-160.
11. C Ripamonti (1993) Management of bowel obstruction in patients with advanced terminal cancer. Support Care Oncol 9 10-13.
12. WM Hogan and MP Boente (1993) The role of surgery in the management of recurrent gynecologic cancer. Semin Oncol 20 462-472.
13. JW Hoskins and SC Rubin (1991) Surgery in the treatment of patients with advanced ovarian cancer. Semin Oncol 18 213-221.
14. KF Tamussino, PC Lim, MJ Webb, et al. (2001) Gastrointestinal surgery in patients with ovarian cancer. Gynecol Oncol 80 79-84.
15. SC Rubin, I Benjamin, WJ Hoskins, et al. (1989) Intestinal surgery in gynecologic oncology. Gynecol Oncol 34 30-33.
16. S Pecorelli, E Sartori and A Santin (1994) Follow-up after primary therapy: Management of the symptomatic patient-surgery. Gynecol Oncol 55 S138-S142.
17. C Ripamonti (1994) Management of bowel obstruction in advanced cancer. Curr Opin Oncol 6 351-357.
18. A Gadducci, S Cosio, AA Fanucchi and AR Genazzani (2001) Malnutrition and cachexia in ovarian cancer patients: Pathophysiology and management. Anticancer Res 21 2941-2948.
19. JC Tunca, DA Buchler, EA Mack, et al. (1981) The management of ovarian-cancer-caused bowel obstruction. Gynecol Oncol 12 186-192.
20. E Tsahalina, RP Woolas, PG Carter, et al. (1999) Gastrostomy tubes in patients with recurrent gynaecological cancer and intestinal obstruction. Br J Obstet Gynaecol 106 964-968.
21. HJ Solomon, KH Atkinson, JVM Coppleson, et al. (1983) Bowel complications in the management of ovarian cancer. Aust N Z J Obstet Gynaecol 23 65-68.
22. KC Soo, T Davidson, M Parker, et al. (1988) Intestinal obstruction in patients with gynaecological malignancies. Ann Acad Med Singapore 17 72-75.
23. CWE Redman, MI Shafi, S Ambrose, et al. (1988) Survival following intestinal obstruction in ovarian cancer. Eur J Surg Oncol 14 383-386.
24. DL Clarke-Pearson, NO Chin, ER DeLong, et al. (1987) Surgical management of intestinal obstruction in ovarian cancer. Gynecol Oncol 26 11-18.
25. FAN Zoetmulder, JM Helmerhorst, FV Coevorden, et al. (1994) Management of bowel obstruction in patients with advance ovarian cancer. Eur J Cancer 30A 1625-1628.
26. DL Clarke-Pearson, ER DeLong, N Chin, et al. (1988) Intestinal obstruction in patients with ovarian cancer-variables associated with surgical complications and survival. Arch Surg 123 42-45.
27. R Lund, M Hansen, F Lundvall, et al. (1989) Intestinal obstruction in patients with advanced carcinoma of the ovaries treated with combination chemotherapy. Surg Gynecol Obstet 169 213-218.
28. WJ Mann, PT Calayag, JP Muffoletto, et al. (1991) Management of gastric outlet obstruction caused by ovarian cancer. Gynecol Oncol 40 277-279.
29. LB Katz, A Frankel, C Cohen and G Slater (1981) Ovarian carcinoma complicated by gastric outlet obstruction. J Surg Oncol 18 261-264.
30. HB Krebs, J Walsh and DR Goplerud (1982) Gastric outlet obstruction caused by ascitic fluid entrapment in the lesser sac-a complication of ovarian cancer: report of two cases. Gynecol Oncol 14 105-111.
31. JA Spencer, BA Crosse, RA Mannion, et al. (2000) Gastroduodenal obstruction from ovarian cancer: imaging features and clinical outcome. Clin Radiol 55 264-272.
32. M Baines, DJ Oliver and RL Carter (1985) Medical management of intestinal obstruction in patients with advanced malignant disease: A clinical and pathological study. Lancet 2 990-993.
33. V Ventafridda, C Ripamonti, A Caraceni, et al. (1990) The management of inoperable gastrointestinal obstruction in terminal cancer patients. Tumori 76 389-393.
34. SC Rubin (1992) Surgery for ovarian cancer. Hematol Oncol Clin North Am 6 851-865.
35. RL Glass and RJ LeDuc (1980) Small intestinal obstruction for peritoneal carcinomatosis. Surgery 87 611-615.
36. SC Rubin (1999) Intestinal obstruction in advanced ovarian cancer: What does the patient want? Gynecol Oncol 75 311-312.
37. MS Piver (2000) The Randall/Rubin article reviewed. Oncol 14 1167-1168.
38. JE Larson, ES Podczaski, A Manetta, et al. (1989) Bowel obstruction in patients with ovarian carcinoma: Analysis of prognostic factors. Gynecol Oncol 35 61-65.
39. TW Castaldo, ES Petrilli, SC Ballon and LD Lagasse (1981) Intestinal operations in patients with ovarian carcinoma. Am J Obstet Gynecol 139 80-84.
40. HB Krebs and DR Goplerud (1983) Surgical management of bowel obstruction in advanced ovarian carcinoma. Obstet Gynecol 61 327-330.
41. P Jong, J Sturgeon and CG Jamieson (1995) Benefit of palliative surgery for bowel obstruction in advanced ovarian cancer. Can J Surg 38 454-457.
42. B van Ooijen, MEL van der Burg, AST Planting, et al. (1993) Surgical treatment or gastric drainage only for intestinal obstruction in patients with carcinoma of the ovary or peritoneal carcinomatosis of other origin. Surg Gynecol Obstet 176 469-474.
43. LA King, LF Carson, N Konstantinides, et al. (1993) Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: What have we learned in a decade of experience? Gynecol Oncol 51 377-382.
44. DA August, D Thorn, RL Fisher and CM Welchek (1991) Home parenteral nutrition for patients with inoperable malignant bowel obstruction. JPEN J Parenter Enteral Nutr 15 323-327.
45. JM Malone, T Koonce, DM Larson, et al. (1986) Palliation of small bowel obstruction by percutaneous gastrostomy in patients with progressive ovarian carcinoma. Obstet Gynecol 68 431-433.
46. WH Marks, MF Perkal and PE Schwartz (1993) Percutaneous endoscopic gastrostomy for gastric decompression in metastatic gynecologic malignancies. Surg Gynecol Obstet 177 573-576.
47. MP Hopkins, JA Roberts and GW Morley (1987) Outpatient management of small bowel obstruction in terminal ovarian cancer. J Reprod Med 32 827-829.
48. LL Herman, WJ Hoskins and M Shike (1992) Percutaneous endoscopic gastrostomy for decompression of the stomach and small bowel. Gastrointest Endosc 38 314-318.
49. G Mangili, M Franchi, A Mariani, et al. (1996) Octreotide in the management of bowel obstruction in terminal ovarian cancer. Gynecol Oncol 61 345-348.
50. S Mercadante, M Sapio and R Serretta (1997) Treatment of pain in chronic bowel subobstruction with self-administration of methadone. Support Care Cancer 5 327-329.
51. JR Fernandes, RJ Seymour and S Suissa (1988) Bowel obstruction in patients with ovarian cancer: A search for prognostic factors. Am J Obstet Gynecol 158 244-249.
52. AS Ketcham, RC Hoye, YH Pilch and DL Morton (1970) Delayed intestinal obstruction following treatment for cancer. Cancer 25 406-410.
53. SJ Dudrick, TG Jensen and BJ Rowlands (1980) Nutritional support: Assessment and indications. M Dietel (Eds) Nutrition in Clinical Surgery Baltimore: Williams & Wilkins 9-27.
54. NR Abu-Rustum, RR Barakat, E Venkatraman and D Spriggs (1997) Chemotherapy and total parenteral nutrition for advanced ovarian cancer with bowel obstruction. Gynecol Oncol 64 493-495.
55. GJC Harris, AJ Senagore, IC Lavery and VW Fazio (2001) The management of neoplastic colorectal obstruction with colonic endoluminal stenting devices. Am J Surg 181 499-506.
56. RM Soetikno and DL Carr-Locke (1999) Expandable metal stents for gastric outlet, duodenal, and small intestinal obstruction. Gastrointest Endosc Clin North Am 9 447-458.
57. J Carter, S Valmadre, C Dalrymple, et al. (2002) Management of large bowel obstruction in advanced ovarian cancer with intraluminal stents. Gynecol Oncol 84 176-179.
58. HB Krebs and DR Goplerud (1984) The role of intestinal intubation in obstruction of the small intestine due to carcinoma of the ovary. Surg Gynecol Obstet 158 467-471.
59. TC Randall and SC Rubin (2000) Management of intestinal obstruction in the patient with ovarian cancer. Oncology 14 1159-1163.
60. RE Brolin (1984) Partial small bowel obstruction. Surgery 95 145-149.
61. DD Douglas and JF Morissey (1978) A new technique for rapid endoscope-assisted intubation of the small intestine. Arch Surg 113 196-198.
62. A Munro and PF Jones (1978) Operative intubation in the treatment of complicated small-bowel obstruction. Br J Surg 65 123-127.
63. D Pictus, MV Marx and PJ Weyman (1988) Chronic intestinal obstruction: value of percutaneous gastrostomy tube placement. Am J Radiol 150 295-297.
64. MWL Gauderer, JL Ponsky and RJ Izant (1980) Gastrostomy without laparotomy: A percutaneous endoscopic technique. J Pediatr Surg 15 872-875.
65. JS Wills and JT Oglesby (1983) Percutaneous gastrostomy. Radiology 149 449-453.
66. MD Adelson and MH Kasowitz (1993) Percutaneous endoscopic drainage gastrostomy in the treatment of gastrointestinal obstruction from intraperitoneal malignancy. Obstet Gynecol 81 467-471.
67. MJ Lee, S Saini, JA Brink, et al. (1991) Malignant small bowel obstruction and ascites: Not a contraindication to percutaneous gastrostomy. Clin Radiol 44 332-334.
68. JL Ponsky, MWL Gauderer and TA Stellato (1983) Percutaneous endoscopic gastrostomy-review of 150 cases. Arch Surg 118 913-914.
69. WH Isbister, P Elder and L Symons (1990) Non-operative management of malignant intestinal obstruction. J R Coll Surg Edinb 35 369-372.
70. RL Fainsinger, K Spachynski, J Hanson and E Bruera (1994) Symptom control in terminally ill patients with malignant bowel obstruction. J Pain Symptom Manage 9 12-18.
71. M Baines (1993) The pathophysiology and management of malignant intestinal obstruction. D Doyle, GWC Hanks, N MacDonald (Eds) Oxford Test Book of Palliative Medicine Oxford: Oxford Medical Publication 311-316.
72. DB Reid (1988) Palliative management of bowel obstruction. Med J Aust 148 54-57.
73. RG Twycross and SA Lack (1986) Gastrointestinal obstruction. RG Twycross, SA Lack (Eds) Symptom Control in Advanced Cancer: Alimentary Symptoms vol 11 London: Pitman 239-257.
74. VR Bauer, E Gross, V Scarselli, et al. (1968) Uber wirkungunterchiede van atopin, scopolamin und einigen ihren quartaren eviate nach subcutaner und enteralen gabe unter besonderer berucksichti-gung des scopolamine-n-butylbromids. Arzneimittelforschung 18 1132-1137.
75. N Weiner (1980) Atropine, scopolamine and related antimuscarinic drugs. A Goodman-Gilman, L Goodman, A Gilman (Eds) The Pharmacological Basis of Therapeutics New York: Macmillan 120-137.
76. F DeConno, A Caraceni, E Zecca, et al. (1991) Continuous subcutaneous infusion of hyoscine butylbromide reduces secretions in patients with gastrointestinal obstruction. J Pain Symptom Manage 6 484-486.
77. S Reichlin (1983) Medical progress: Somatostatin. N Engl J Med 309 1495-1501.
78. S Mercadante and S Maddaloni (1992) Octreotide in the management of inoperable gastrointestinal obstruction in terminal cancer patients. J Pain Symptom Manage 7 496-498.
79. S Mercadante (1993) The use of octreotide in bowel obstruction. Palliat Med 7 78.
80. K Kutz, E Muesh and J Rosenthaler (1986) Pharmacokinetics of SMS 201-995 in healthy subjects. Scand J Gastroenterol 21(Suppl 119), 65-72.
81. D Khoo, E Hall, R Motson, J Riley, et al. (1994) Palliation of malignant intestinal obstruction using octreotide. Eur J Cancer 30A 28-30.
82. S Mercadante, E Spoldi, A Carceni, et al. (1993) Octreotide in relieving gastrointestinal symptoms due to bowel obstruction. Palliat Med 7 295-299.
83. D Khoo, G Riley and J Waxman (1992) Control of emesis in bowel obstruction in terminally ill patients. Lancet 339 375-376.
84. A Dean, D Bridge and JM Lickiss (1994) The palliative effects of octreotide in malignant disease. Ann Acad Med Singapore 23 212-215.
85. F Stiefel and R Morant (1993) Vapreotide, a new somatostatin analogue in the palliative management of obstructive ileus in advanced cancer. Support Care Cancer 1 57-58.
86. WC Farr (1990) The use of corticosteroids for symptom management in terminally ill patients. Am J Hospice Care 1 41-46.
87. E Bruera and T Schoeller (1992) Patient-controlled analgesia in cancer pain. VT DeVita, S Helman, SA Rosenberg (Eds) Principles and Practice of Oncology Philadelphia: Lippincott 7.
88. C Chapman, J Bosscher, S Remmenga, et al. (1991) A technique for managing terminally ill ovarian carcinoma patients. Gynecol Oncol 41 88-91.
89. SJ Dudrick, DW Wilmore, HM Vars and JE Rhoads (1968) Long term parenteral nutrition with growth, development, and positive nitrogen balance. Surgery 64 134-142.
90. JH Ford, RC Dudan, JS Bennett and HE Averette (1972) Parenteral hyperalimentation in gynecologic oncology patients. Gynecol Oncol 1 70-75.
91. Oley/ASPEN Information System (OASIS) (1988) Home nutritional support patient registry: Annual report, 1986 data Albany, NY: Oley Foundation
92. MA Schattner and M Shike (2000) Nutritional Support of Patients with Gynecologic Cancers. WJ Hoskins, CA Perez, RC Young (Eds) Principles and Practice of Gynecologic Oncology 3rd ed. Philadelphia: Lippincott Williams & Wilkins 611-627.
93. JR Wesley (1983) Home parenteral nutrition: indications, principles, and cost-effectiveness. Compr Ther 9 29-36.
94. American College of Physicians: Position paper (1989) Parenteral nutrition in patients receiving cancer chemotherapy. Ann Intern Med 110 734-736.
95. L Howard (1992) Home parenteral nutrition in patients with a cancer diagnosis. JPEN J Parenter Enteral Nutr 16(Suppl), 93-99.
96. L Howard, M Ament, CR Fleming, et al. (1995) Current use and clinical outcome of home parenteral and enteral nutrition therapies in the United States. Gastroenterology 109 355-365.
97. EM Copeland (1982) Intravenous hyperalimentation and chemotherapy: An update. JPEN J Parenter Enteral Nutr 6 236-239.
98. JW Sharp and T Roncagli (1993) Home parenteral nutrition in advanced cancer. Cancer Pract 1 119-124.
99. BH Scribner, JJ Cole and TC Christopher (1970) Long term total parenteral nutrition: the concept of an artificial gut. JAMA 212 457-463.
100. WJ Byrne, ME Ament, M Burke and E Fonkalsrud (1979) Home parenteral nutrition. Surg Gynecol Obstet 149 593-599.
101. RL Fainsinger, K Chan and E Bruera (1992) Total parenteral nutrition for a terminally ill patient? J Palliat Care 8 30-32.
102. GF Schwartz, HL Green, ML Bendon, et al. (1971) Combined parenteral hyperalimentation and chemotherapy in the treatment of disseminated solid tumors. Am J Surg 121 169-173.
103. EM Copeland, BV MacFayden Jr, VJ Lanzotti and SJ Dudrick (1975) Intravenous hyperalimentation as an adjunct to cancer chemotherapy. Am J Surg 129 167-173.
104. MP Hopkins, JA Roberts and GW Morley (1987) Outpatient management of small bowel obstruction in terminal ovarian cancer. J Reprod Med 32 827-829.
105. JP Baker, AS Detsky and DE Wesson (1982) Nutritional assessment: A comparison of clinical judgment and objective measurements. N Engl J Med 306 969-972.
106. SF Lowry, JC Smith Jr and MF Brennan (1981) Zinc and copper replacement during total parenteral nutrition. Am J Clin Nutr 34 1853-1860.
107. AK Kirkemo, ME Burt and NJ Brennan (1982) Serum Vitamin level maintenance in cancer patients on TPN. Am J Clin Nutr 35 1003-1009.
108. M Shike, DM Russel, AS Detsky, et al. (1984) Changes in body composition in patients with small cell lung cancer: The effect of TPN as an adjunct for chemotherapy. Ann Intern Med 101 303-309.
109. DL Clarke-Pearson, GC Rodriguez and M Boente (2001) Palliative surgery for epithelial ovarian cancer. SC Rubin, GP Sutton (Eds) Ovarian Cancer 2nd ed. Philadelphia: Lippincott Williams & Wilkins 329-344.
110. L Cozzaglio, F Balzola, F Cosentino, et al. (1997) Outcome of cancer patients receiving home parenteral nutrition. J PEN 21 339-342.
111. The Veterans Affairs Total Parenteral Nutrition Cooperative Study Group (1991) Perioperative total parenteral nutrition in surgical patients. N Engl J Med 325 525-532.
112. MF Brennan, PWT Pisters, M Posner, et al. (1994) A prospective randomized trial of total parenteral nutrition after major pancreatic resection for malignancy. Ann Surg 220 436-441.
113. S Klein, J Simes and GL Blackburn (1986) Total parenteral nutrition and cancer clinical trials. Cancer 58 1378-1386.
114. BF Smale, JL Mullen, GP Buzby and EF Rosato (1981) The efficacy of nutritional assessment and support in cancer surgery. cancer 47 2375-2381.
115. D Brown, JA Roberts, TE Elkins, et al. (1994) Hard choices: The gynecologic cancer patient's end-of-life pReferences. Gynecol Oncol 55 355-362.
116. RM McCann, WJ Hall and A Groth-Juncker (1994) Comfort care for terminally ill patients. JAMA 272 1263-1266.
117. JC Fletcher and EM Spencer (1995) Incompetent on the slippery slope. Lancet 345 271-272.
118. A Waller, A Adunski and M Hershkowitz (1991) Terminal dehydration and intravenous fluids. Lancet 337 745.
119. RE Cranford (1991) Neurologic syndromes and prolonged survival: When can artificial nutrition and hydration be forgone? Law Med Health Care 19 13-22.
120. R Dunlop, JE Ellershaw, MJ Baines, et al. (1995) On withholding nutrition and hydration in the terminally ill: Has palliative medicine gone too far? A reply. J Med Ethics 21 141-143.
121. LA Printz (1988) Is withholding hydration a valid comfort measure in the terminally ill? Geriatrics 43 84-88.
122. P Schmitz (1991) The process of dying with and without feeding and fluids by tube. Law Med Health Care 19 23-26.
123. JV Zerwekh (1983) The dehydration question. Nursing 13 47-51.
124. MC Parker and MJ Barnes (1996) Intestinal obstruction in patients with advanced malignant disease. Br J Surg 83 1-2.
125. GB Feldman, RC Knapp, SE Order and S Hellman (1972) The role of lymphatic obstruction in the formation of ascites in a murine ovarian carcinoma. Cancer Res 32 1663-1666.
126. P Holm-Nielsen (1953) Pathogenesis of ascites in peritoneal carcino-matosis. Acta Pathol Microbiol Scand 33 10-21.
127. P Appelqvist, J Silvo, L Salema and S Kostianien (1982) On the treatment and prognosis of malignant ascites: Is the survival time determined when the abdominal paracentesis is needed? J Surg Oncol 20 238-242.
128. CM Knauer and HM Lowe (1967) Hemodynamics in the cirrhotic patient during paracentesis. N Engl J Med 276 491-496.
129. P Gines, V Arroyo, E Quintero, et al. (1987) Comparison of paracentesis and diuretics in the treatment of cirrhosis with tense ascites—results of a randomized study. Gastroenterology 93 234-241.
130. TF Halpin and TO McCann (1971) Dynamics of body fluids following the rapid removal of large volume ascites. Am J Obstet Gynecol 110 103-106.
131. DP Cruikshank and HJ Buchsbaum (1973) Effects of rapid paracentesis-cardiovascular dynamics and body fluid composition. JAMA 225 1361-1362.
132. WH Gotlieb, B Feldman, O Feldman-Moran, et al. (1998) Intraperitoneal pressures and clinical parameters of total paracentesis for palliation of symptomatic ascites in ovarian cancer. Gynecol Oncol 71 381-385.
133. D Mulvaney (1955) Vesicocoelomic drainage for relief of ascites. Lancet 2 747-749.
134. FB Stehman and CE Ehrlich (1984) Peritoneo-cystic shunt for malignant ascites. Gynecol Oncol 18 402-407.
135. AN Smith (1962) Peritoneocaval shunt with a Holter valve in the treatment of ascites. Lancet 1 662-671.
136. AN Smith, RM Preshaw and WH Bisset (1962) The drainage of resistant ascites by a modification of the Spitz-Holter valve technique. JR Coll Surg Edinb 7 289-294.
137. HH LeVeen, G Christoudias, IP Moon, et al. (1974) Perioneo-venous shunting for ascites. Ann Surg 180 580-591.
138. HH LeVeen, S Wapnick and S Grosberg (1976) Further experience with peritoneo-venous shunts for ascites. Ann Surg 184 574-581.
139. RH Lund and JB Newkirk (1979) Peritoneo-venous shunting system for surgical management of ascites. Contemp Surg 14 31-45.
140. P Gullstrand, A Alwmark, B Borjesson, et al. (1982) Peritoneovenous shunting for intractable ascites. Scand J Gastroenterol 17 1009-1012.
141. AK Straus, DL Roseman and TM Shapiro (1979) Peritoneovenous shunting in the management of malignant ascites. Arch Surg 114 489-491.
142. RG Souter, C Wells, D Tarin and MGW Kettlewell (1985) Surgical and pathologic complications associated with peritoneovenous shunts in management of malignant ascites. Cancer 55 1973-1978.
143. T Sonnenfeld and G Tyden (1986) Peritoneovenous shunts for malignant ascites. Acta Chir Scand 152 117-121.
144. J Oosterlee (1980) Peritoneovenous shunting for ascites in cancer patients. Br J Surg 67 663-666.
145. GB Battaglia, V Levi D'Ancona, N Farsi and L Boffi (1982) Preliminary experience in the treatment of rebel ascites from ovarian cancer with the peritoneo-venous shunt of LeVeen. Eur J Gyneacol Oncol 3 88-90.
146. IM Ariel, R Oropeza and GT Pack (1966) Intracavitary administration of radioactive isotopes in the control of effusions due to cancer—results in 267 patients. Cancer 19 1096-1102.
147. GL Jackson and NM Blosser (1981) Intracavitary chromic phosphate 32 P colloidal suspension therapy. Cancer 48 2596-2598.
148. W Paladine, TJ Cunningham, R Sponzo, et al. (1976) Intracavitary bleomycin in the management of malignant effusions. Cancer 38 1903-1908.
149. JD Bitran (1985) Intraperitoneal bleomycin-pharmacokinetics and results of a phase 2 trial. Cancer 56 2420-2423.
150. RF Ozols, RC Young, JL Speyer, et al. (1982) Phase 1 and pharmacological studies of Adriamycin administered intraperitoneally to patients with ovarian cancer. Cancer Res 42 4265-4269.
151. RF Kefford, RL Woods, RM Fox and MHN Tattersall (1980) Intracavitary adriamycin, nitrogen mustard, and tetracycline in the control of malignant effusions—a randomized study. Med J Aust 2 447-448.
152. PL Cherchi, A Campiglio, A Rubattu, et al. (1990) Endocavitary beta-interferon in neoplastic effusions. Eur J Gynaecol Oncol 11 477-479.
153. WR Bezwoda, L Seymour and R Dansy (1989) Intraperitoneal recombinant interferon-alpha 2b for recurrent malignant ascites due to ovarian cancer. Cancer 64 1029-1033.
154. JL Currie, S Gall, JC Weed Jr and WT Creasman (1983) Intracavitary Corynebacterium parvum for treatment of malignant effusions. Gynecol Oncol 16 6-14.
155. R Buckman, C DeAngelis, P Shaw, et al. (1992) Intraperitoneal therapy of malignant ascites associated with carcinoma of ovary and breast using radioiodinated monoclonal antibody 2G3. Gynecol Oncol 47 102-109.
156. M Kamada, Y Sakamoto, H Furumoto, et al. (1989) Treatment of malignant ascites with allogeneic and autologous lymphokine-activated killer cells. Gynecol Oncol 34 34-37.